Aloxi web

Impact on the Practice

BREAKTHROUGH OR DELAYED CINV DIMINISHES PRACTICE EFFICIENCY

In a study of 20 community-based oncology practices, the estimated time to manage an extreme CINV event was 4.25 hours (255 mins) of labor time.¹
The greatest costs to the practice were Phone Assessment, Nurse Evaluation, Physician Evaluation, Triage and I.V. Antiemetic Rescue Medication.¹

ALOXI-Average Phone Time by Site

In a separate study, a majority of nurses (68.5%) reported spending > 1 hour a week on the telephone with patients experiencing breakthrough or delayed CINV.²

References

Vanscoy GJ, Fortner B, Smith R, et al. Preventing chemotherapy-induced nausea and vomiting: the economic implications of choosing antiemetics. Community Oncol. 2005;2:127-132.
Johnson J, Rittenberg C. An opportunity to reduce telephone follow-up time by nurses assessing the status of patients' nausea and vomiting postchemotherapy. Poster presented at: Oncology Nursing Society 29^th Annual Congress; April 29-May 2, 2004; Anaheim, Calif.

During initial and repeat courses of chemotherapy, ALOXI helps prevent and control nausea and vomiting the day following chemotherapy that is highly likely to cause nausea and vomiting, and for up to 5 days following chemotherapy that is likely to cause nausea and vomiting. The most frequent side effects of ALOXI include headache and constipation. If you have or may develop significant heart rhythm changes, talk with your healthcare professional before receiving ALOXI.

ALOXI is available by prescription only. Please see the important product information for ALOXI for more information.

This site does not contain everything that is known about ALOXI. If you would like to know more, talk to your healthcare professional.